Tudóstér has been updated, the site is accessible at https://tudoster.unideb.hu

Arany József

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2019-2025

2025

Ádám, D., Arany, J., Tóth, K. F., Póliska, S., Váradi, J., Kolozsi, P., Tóth, D., Niehues, H., van den Bogaard, E. H., Soeberdt, M., Abels, C., Oláh, A.: Fluoxetine exerts anti-proliferative effect in human epidermal keratinocytes.
Arch Dermatol Res. 317 (1), 1-6, (article identifier: 277), 2025.

doi DEA WoS

Journal metrics:

Q1 Dermatology (2023)

Q2 Medicine (miscellaneous) (2023)

2024

Tóth, K. F., Ádám, D., Arany, J., Ramirez, Y. A., Bíró, T., Drake, J. I., O'Mahony, A., Szöllősi, A. G., Póliska, S., Kilic, A., Soeberdt, M., Abels, C., Oláh, A.: Fluoxetine exerts anti-inflammatory effects on human epidermal keratinocytes and suppresses their endothelin release.
Exp. Dermatol. 33 (1), 1-15, (article identifier: 14988), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry (2023)

D1 Dermatology (2023)

Q2 Molecular Biology (2023)

Ádám, D., Arany, J., Tóth, K. F., Pető, O., Nyitrai, T., Tóth, I. B., Póliska, S., Zouboulis, C. C., Oláh, A.: The TRPM5 antagonist triphenylphosphine oxide increases sebaceous lipogenesis and modulates immune phenotype of human sebocytes in a TRPM5-independent manner.
J. Invest. Dermatol. 144, S313, 2024.

doi DEA

2023

Arany, J., Ádám, D., Cseszlai, M., Nyitrai, T., Zouboulis, C. C., Oláh, A.: Adenosine receptors are novel regulators of human sebocyte biology.
J. Invest. Dermatol. 143 (Suppl_11), S355, 2023.

doi DEA

Tóth, K. F., Ádám, D., Arany, J., Ramirez, Y. A., Bíró, T., Drake, J. I., O'Mahony, A., Szöllősi, A. G., Kilic, A., Soeberdt, M., Abels, C., Oláh, A.: Fluoxetine exerts anti-inflammatory effects on human epidermal keratinocytes, and suppresses endothelin release via inhibiting PI3K.
J. Invest. Dermatol. 143 (5), S126, 2023.

doi DEA

Tóth, K. F., Ádám, D., Arany, J., Ramirez, Y. A., Bíró, T., Drake, J. I., O'Mahony, A., Szöllősi, A. G., Kilic, A., Soeberdt, M., Abels, C., Oláh, A.: Fluoxetine exerts anti-inflammatory effects on human epidermal keratinocytes, and suppresses their endothelin release.
J. Invest. Dermatol. 143 (11), S361, 2023.

doi DEA

Ádám, D., Arany, J., Pető, O., Tóth, I. B., Zouboulis, C. C., Oláh, A.: The TRPM5 antagonist TPPO increases sebaceous lipogenesis and exerts pro-inflammatory effects via activation of Akt and p38 MAPK cascades.
J. Invest. Dermatol. 143 (11), S354, 2023.

doi DEA

Alimohammadi, S., Pénzes, Z., Horváth, D., Gyetvai, Á., Bácsi, A., Kis, G., Németh, Á., Arany, J., Oláh, A., Lisztes, E., Tóth, I. B., Bíró, T., Szöllősi, A. G.: TRPV4 activation increases the expression of CD207 (Langerin) of monocyte-derived Langerhans cells, without affecting their maturation.
J. Invest. Dermatol. 143 (5), 801-811, 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

Q2 Cell Biology

D1 Dermatology

Q1 Molecular Biology

2022

Ádám, D., Arany, J., Tóth, K. F., Tóth, I. B., Szöllősi, A. G., Oláh, A.: Opioidergic Signaling: a Neglected, Yet Potentially Important Player in Atopic Dermatitis.
Int. J. Mol. Sci. 23 (8), 4140, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

2019

10.

Tóth, K. F., Ádám, D., Arany, J., Faragó, P., Arbiser, J. L., Zouboulis, C. C., Bíró, T., Oláh, A.: The putative tribbles homolog 3 (TRIB3) activator honokiol suppresses lipogenesis, and exerts anti-proliferative as well as anti-inflammatory effects on human sebocytes.
J. Invest. Dermatol. 139 (9S), S319, 2019.

doi DEA WoS